ArticleOncotarget2016

Copper as a target for prostate cancer therapeutics: copper-ionophore pharmacology and altering systemic copper distribution.

Delphine Denoyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.